1 | ARRDC3, ELP3, GATA5
|
| Promoter hypermethylation may be an important mechanism of the transcriptional inactivation of ARRDC3, GATA5, and ELP3 in invasive ductal breast carcinoma.
|
| Wang D, Yang PN, Chen J, Zhou XY, Liu QJ, Li HJ, Li CL.
|
| Mol Cell Biochem 396(1-2):67-77. doi: 10.1007/s11010-014-2143-y.
2014
|
2 | ARRDC3, NEDD4
|
| Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor.
|
| Nabhan JF, Pan H, Lu Q.
|
| EMBO Rep 11(8):605-11. Epub 2010 Jun 18.PMID: 20559325 2010
|
3 | ARRDC3, ITGB4
|
| ARRDC3 suppresses breast cancer progression by negatively regulating integrin beta4.
|
| Draheim KM, Chen HB, Tao Q, Moore N, Roche M, Lyle S.
|
| Oncogene 29(36):5032-47. Epub 2010 Jul 5. 2010
|
4 | ARRDC3
|
| Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.
|
| Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, Schreiter ER, Lee RT.
|
| J Biol Chem 284(37):24996-5003. Epub 2009 Jul 15.
2009
|
5 | ARRDC3
|
| Thioredoxin-binding protein-2-like inducible membrane protein is a novel vitamin D3 and peroxisome proliferator-activated receptor (PPAR)gamma ligand target protein that regulates PPARgamma signaling.
|
| Oka S, Masutani H, Liu W, Horita H, Wang D, Kizaka-Kondoh S, Yodoi J.
|
| Endocrinology 147(2):733-43. Epub 2005 Nov 3.
2006
|